TG Therapeutics Inc (TGTX)
24.63
-2.27
(-8.44%)
USD |
NASDAQ |
Nov 04, 13:11
TG Therapeutics Enterprise Value: 4.050B for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 4.050B |
| October 31, 2024 | 3.765B |
| October 30, 2024 | 3.776B |
| October 29, 2024 | 3.866B |
| October 28, 2024 | 3.655B |
| October 25, 2024 | 3.502B |
| October 24, 2024 | 3.480B |
| October 23, 2024 | 3.466B |
| October 22, 2024 | 3.640B |
| October 21, 2024 | 3.658B |
| October 18, 2024 | 3.494B |
| October 17, 2024 | 3.592B |
| October 16, 2024 | 3.678B |
| October 15, 2024 | 3.689B |
| October 14, 2024 | 3.420B |
| October 11, 2024 | 3.319B |
| October 10, 2024 | 3.265B |
| October 09, 2024 | 3.275B |
| October 08, 2024 | 3.267B |
| October 07, 2024 | 3.185B |
| October 04, 2024 | 3.327B |
| October 03, 2024 | 3.321B |
| October 02, 2024 | 3.350B |
| October 01, 2024 | 3.420B |
| September 30, 2024 | 3.507B |
| Date | Value |
|---|---|
| September 27, 2024 | 3.575B |
| September 26, 2024 | 3.497B |
| September 25, 2024 | 3.500B |
| September 24, 2024 | 3.494B |
| September 23, 2024 | 3.485B |
| September 20, 2024 | 3.702B |
| September 19, 2024 | 3.799B |
| September 18, 2024 | 3.795B |
| September 17, 2024 | 3.768B |
| September 16, 2024 | 3.739B |
| September 13, 2024 | 3.559B |
| September 12, 2024 | 3.476B |
| September 11, 2024 | 3.457B |
| September 10, 2024 | 3.528B |
| September 09, 2024 | 3.562B |
| September 06, 2024 | 3.296B |
| September 05, 2024 | 3.208B |
| September 04, 2024 | 3.304B |
| September 03, 2024 | 3.386B |
| August 30, 2024 | 3.522B |
| August 29, 2024 | 3.525B |
| August 28, 2024 | 3.500B |
| August 27, 2024 | 3.463B |
| August 26, 2024 | 3.596B |
| August 23, 2024 | 3.672B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
374.24M
Minimum
Jun 16 2022
7.393B
Maximum
Dec 21 2020
2.597B
Average
2.326B
Median
Jul 01 2020
Enterprise Value Benchmarks
| ADMA Biologics Inc | 4.558B |
| Varex Imaging Corp | 806.57M |
| Rhythm Pharmaceuticals Inc | 2.817B |
| AdaptHealth Corp | 3.429B |
| Inspire Medical Systems Inc | 5.248B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 6.879M |
| Revenue (Quarterly) | 73.47M |
| Total Expenses (Quarterly) | 64.65M |
| EPS Diluted (Quarterly) | 0.04 |
| Gross Profit Margin (Quarterly) | 88.70% |
| Profit Margin (Quarterly) | 9.36% |
| Earnings Yield | 2.44% |
| Operating Earnings Yield | 2.68% |
| Normalized Earnings Yield | 2.436 |